Non‐islet‐cell tumor hypoglycemia as first manifestation of an advanced hepatocellular carcinoma

Abstract

Abstract In a nondiabetic patient, fasting hypoglycemia is uncommon and warrants careful assessment. Although rare, NICTH should be considered in patients with recurrent hypoglycemia especially in those with risk factors for HCC.

Keywords

• hepatocellular carcinoma
• hypoglycemia
• IGF‐2
• NICTH